ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $23,000 | -30.3% | 250 | -55.2% | 0.02% | -37.5% |
| Q3 2021 | $33,000 | -5.7% | 558 | +8.1% | 0.02% | -7.7% |
| Q2 2021 | $35,000 | +150.0% | 516 | +155.4% | 0.03% | +136.4% |
| Q1 2021 | $14,000 | -30.0% | 202 | -22.3% | 0.01% | -35.3% |
| Q4 2020 | $20,000 | -72.2% | 260 | -73.1% | 0.02% | -73.8% |
| Q3 2020 | $72,000 | +1100.0% | 968 | +858.4% | 0.06% | +828.6% |
| Q2 2020 | $6,000 | – | 101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |